🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03934957
Recruiting Observational

Hamburg City Health Study - a German Cohort Study

NCT03934957 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2016-02-08
Last updated
2019-05-02

Condition(s) studied

Coronary Heart DiseaseStrokeDementiaCancerHealth CareVascular DiseasesPeriodontal DiseasesOcular DiseasesRespiratory DiseaseObesity

Study summary

The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.

Eligibility

Sex
ALL
Min age
45 Years
Max age
74 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Inhabitant of the city of Hamburg at the time of inclusion into the study (Inclusion is time of written consent) * Age 45 to 74 years * Personally signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation * Physical or psychological incapability to travel to the study center and to cooperate in the investigations

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitätsklinikum Hamburg-Eppendorf Hamburg Germany Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03934957 on ClinicalTrials.gov ↗ ← All trials in Germany